Picato for the Treatment of Molluscum Contagiosum in Immunocompromised

Clinical Trial Summary

Patients at least 18 years of age will be enrolled in the study to assess the efficacy and tolerability of Picato gel in the treatment of molluscum contagiosum. Patients must have an immunocompromised condition due to taking immunosuppressive drugs or having an inherited disease affecting the immune system.

See also
Status	Clinical Trial	Phase
Completed	`NCT03017846` - Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2	Phase 2
Recruiting	`NCT05937672` - Cold Atmospheric Plasma Device Extension Study	Phase 3
Completed	`NCT04535531` - A Phase 3 Molluscum Contagiosum Efficacy and Safety Study	Phase 3
Completed	`NCT02902822` - Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo	N/A
Completed	`NCT05897112` - Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum	Phase 1
Withdrawn	`NCT05536882` - MC RCT - BPO vs Adapalene	Phase 3
Completed	`NCT03377790` - Cantharidin Application in Molluscum Patients-1	Phase 3
Completed	`NCT01348386` - Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum	Phase 2/Phase 3
Completed	`NCT05634460` - Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum	Phase 1
Completed	`NCT03186378` - Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.	Phase 2
Completed	`NCT03927716` - A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)	Phase 3
Recruiting	`NCT04476186` - The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children	N/A
Completed	`NCT03927703` - A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC	Phase 3
Completed	`NCT02665260` - Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum	Phase 2
Completed	`NCT03436615` - A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum	Phase 2
Recruiting	`NCT02759900` - Using a Cold Atmospheric Plasma Device to Treat Skin Disorders	N/A
Recruiting	`NCT05680181` - Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin
Completed	`NCT03077750` - A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum	Phase 2
Terminated	`NCT02024581` - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum	Phase 2
Completed	`NCT03377803` - Cantharidin Application in Molluscum Patients	Phase 3

NCT number	NCT03336372
Study type	Interventional
Source	Center for Clinical Studies, Texas
Contact
Status	Withdrawn
Phase	Early Phase 1
Start date	December 20, 2017
Completion date	October 16, 2018

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms